Rezolute (RZLT) Long-Term Investments (2023 - 2025)
Rezolute (RZLT) posted Long-Term Investments of $1.5 million for Q1 2025, down 82.8% sequentially from $8.8 million in Q4 2024, and down 3.75% YoY from $1.6 million in Q1 2024.
Analysis
Rezolute (RZLT) Long-Term Investments (2023 - 2025) Analysis & Trends
Rezolute has reported Long-Term Investments for 3 years, with the latest figure at $1.5 million in Q1 2025.
- Quarterly Long-Term Investments fell 3.75% year-over-year to $1.5 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $1.5 million (down 3.75% YoY) and the FY2024 annual result came in at $263000.0, down 98.4% from the prior year.
- Long-Term Investments fell to $1.5 million in Q1 2025 per RZLT's latest filing, from $8.8 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $26.2 million in Q1 2023 and troughed at $263000.0 in Q2 2024.
- A 3-year average of $8.4 million and a median of $8.1 million in 2023 frame the typical range for Long-Term Investments.
- The widest YoY moves for Long-Term Investments: up 162.53% in 2024, down 98.4% in 2024.
- Over 3 years, Long-Term Investments stood at $3.4 million in 2023, then surged by 162.53% to $8.8 million in 2024, then plunged by 82.8% to $1.5 million in 2025.
- According to Business Quant data, Long-Term Investments over the past three periods registered $1.5 million, $8.8 million, and $9.6 million for Q1 2025, Q4 2024, and Q3 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -4.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 1.77 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.17 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 372.10 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 8.80 Mn |
| Sep 30, 2024 | 9.60 Mn |
| Jun 30, 2024 | 263,000.00 |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 3.40 Mn |
| Sep 30, 2023 | 8.14 Mn |
| Jun 30, 2023 | 16.47 Mn |
| Mar 31, 2023 | 26.21 Mn |